Perioperative sacituzumab govitecan/pembro yields compelling CR rate in MIBC
Interim ENLIGHTED data show promise for padeliporfin VTP therapy in UTUC
PEACE-3 data for radium-223/enzalutamide published in Annals of Oncology
Phase 2 trial launches of combination immunotherapy for mCRPC
